develop
rnaibas
therapeut
potenti
revolution
treatment
option
rang
human
diseas
howev
gene
therapi
major
barrier
progress
lack
method
achiev
measur
effici
deliveri
system
administr
develop
positivereadout
pharmacodynam
transgen
report
mous
model
allow
noninvas
realtim
assess
sirna
activ
model
combin
luciferas
report
gene
control
regulatori
element
lac
operon
escherichia
coli
introduct
sirna
target
lac
repressor
result
increas
luciferas
express
cell
sirna
biolog
activ
five
founder
luciferaseexpress
three
founder
lacexpress
line
gener
character
mate
ubiquit
express
luciferas
lac
line
gener
progeni
luciferas
express
significantli
reduc
compar
parent
line
administr
isopropyl
either
drink
water
given
intraperiton
increas
luciferas
express
eight
mice
examin
fell
rapidli
withdrawn
intraperiton
administr
sirna
target
lac
combin
lipofectamin
result
increas
luciferas
express
liver
control
nontarget
sirna
effect
believ
sensit
posit
readout
pharmacodynam
report
model
use
research
commun
rnaibas
vector
develop
rna
interfer
rnai
power
approach
suppress
express
specif
gene
mammalian
cell
either
basic
research
tool
elucid
gene
function
clinic
set
therapeut
applic
therapeut
strategi
elicit
rnai
involv
target
exogen
gene
pathogen
endogen
gene
play
role
diseas
process
sinc
landmark
discoveri
rnai
number
vivo
studi
involv
sirna
greatli
increas
thousand
studi
report
clinic
trial
involv
sirnaor
shrnabas
drug
open
although
local
deliveri
sirna
may
effect
set
mani
diseas
deliveri
dissemin
bodywid
target
requir
sever
step
toward
enabl
system
deliveri
sirna
includ
improv
chemistri
increas
serum
stabil
reduc
immunostimul
coupl
deliveri
strategi
hydrodynam
inject
liposom
lipidbas
nanoparticl
polyplex
ligandsirna
conjug
inorgan
particl
howev
remain
major
challeng
studi
perform
sirna
given
intraven
biodistribut
studi
fluoresc
radioact
complex
magnet
nanoparticl
although
trace
techniqu
may
intrins
alter
pharmacokinet
label
molecul
time
window
use
studi
limit
sirna
catabol
addit
biodistribut
sirna
indic
biolog
activ
techniqu
assess
sirna
activ
pharmacodynam
depend
natur
molecular
target
exampl
sirna
target
mrna
encod
specif
enzym
pharmacodynam
assess
measur
inhibit
enzym
activ
unfortun
assay
highli
invas
prevent
timeresolv
assess
anim
easi
research
miss
spatial
offtarget
effect
principl
everi
targetexpress
cell
type
bodi
must
evalu
assess
whether
sirna
activ
truli
restrict
intend
target
one
way
address
limit
studi
pharmacodynam
involv
use
transgen
report
mice
diseas
model
ubiquit
select
express
report
gene
gfp
luciferas
test
abil
sirna
silenc
express
target
site
howev
system
ideal
sinc
model
gener
select
express
target
report
gene
mrna
specif
organ
skew
data
give
desir
outcom
ubiquit
express
negativereadout
model
suffer
high
level
background
nontarget
tissu
give
intrins
poor
signaltonois
ratio
therefor
press
need
anim
model
sensit
noninvas
reveal
success
sirna
deliveri
without
need
label
tissu
sampl
previous
develop
induc
vitro
system
use
lac
repressor
sirna
activ
result
posit
readout
luciferas
express
base
wellcharacter
e
colilac
operon
absenc
lactos
lac
repressor
laci
bind
homotetram
lac
oper
laco
locat
within
promot
region
block
transcript
downstream
gene
figur
lactos
synthet
analogu
isopropyl
iptg
caus
conform
chang
repressor
caus
vacat
oper
allow
rna
polymeras
gain
access
promot
initi
transcript
repressor
remov
oper
transcript
lac
operon
resum
introduct
sirna
target
lac
repressor
mrna
reduc
level
repressor
protein
allow
express
report
gene
case
luciferas
downstream
lacocontain
promot
thu
give
posit
readout
rnai
activ
scrabl
et
al
independ
develop
system
bacteri
lac
express
system
mammalian
via
appropri
codon
usag
gener
work
transgen
mous
model
luciferas
express
regul
lac
repressor
could
induc
iptg
administr
drink
water
use
scrabl
construct
recreat
mous
model
creat
test
first
transgen
mous
model
everi
cell
anim
potenti
reveal
everi
site
sirna
biolog
activ
advantag
system
provid
noninvas
readout
allow
timebas
measur
bodywid
effect
sirna
therefor
provid
platform
compar
develop
sirna
vector
system
strategi
adopt
develop
lacregul
luciferas
express
model
base
previous
perform
scrabl
et
al
briefli
transgen
line
compris
hdlacoluc
lacir
gener
subsequ
cross
produc
doubl
transgen
hdlacoluc
x
lacir
offspr
total
five
hdlacoluc
founder
mice
gener
tabl
cross
wildtyp
mice
produc
pup
establish
line
four
five
founder
mice
produc
pup
genotyp
examin
luciferas
express
noninvas
imag
whole
bodi
imag
show
virtual
luciferas
express
pup
founder
togeth
wildtyp
control
mous
figur
tabl
dissect
small
amount
express
could
detect
fallopian
tube
ovari
mous
test
larg
intestin
mous
data
shown
contrast
offspr
founder
mous
individu
show
extens
luciferas
express
figur
express
level
remain
undiminish
time
loss
signal
observ
month
luciferas
express
confirm
truli
ubiquit
follow
cull
dissect
three
individu
organ
reimag
outsid
carcass
express
appear
especi
high
liver
fallopian
tube
ovari
three
anim
figur
pup
mate
wildtyp
mice
ubiquit
luciferas
express
confirm
gener
data
shown
addit
three
lacir
founder
mice
gener
tabl
two
gener
offspr
mate
wildtyp
mice
lac
repressor
express
confirm
western
blot
kda
band
present
organ
examin
transgen
pup
figur
howev
express
highli
variabl
organ
express
high
muscl
spleen
moder
brain
heart
low
lung
kidney
liver
could
detect
follow
increas
amount
sampl
load
onto
gel
contrast
organ
transgen
pup
show
high
express
figur
express
detect
wildtyp
control
mous
transgen
mice
founder
subsequ
mate
wildtyp
mice
produc
gener
establish
line
stabl
ubiquit
luciferas
express
individu
gener
mate
individu
gener
line
order
gener
doubl
transgen
progeni
work
report
system
total
mice
bred
x
cross
mice
x
cross
examin
luciferas
express
figur
supplementari
tabl
overal
broad
rang
total
bodywid
luciferas
express
rang
rel
light
unit
rlu
rlu
observ
total
luciferas
express
individu
x
cross
significantli
lower
offspr
figur
howev
x
mice
low
level
express
figur
supplementari
tabl
contrast
total
luciferas
express
individu
x
cross
significantli
lower
line
figur
given
x
x
mice
share
genet
background
luciferas
reduct
luciferas
express
like
attribut
increas
express
lac
repressor
descend
mice
figur
doubl
transgen
mice
test
induct
luciferas
express
use
iptg
although
mice
respond
eight
mice
show
clear
increas
administ
iptg
either
drink
water
given
intraperiton
ip
repres
exampl
shown
figur
unsurprisingli
mice
high
initi
luciferas
express
level
rlu
fail
show
increas
iptg
treatment
howev
mice
low
level
express
also
fail
induc
eight
mice
success
induc
increas
luciferas
express
observ
individu
lacir
line
greatest
induct
observ
mous
x
show
fivefold
increas
luciferas
express
baselin
rlu
rlu
hour
iptg
administr
drink
water
importantli
luciferas
express
fell
sharpli
follow
withdraw
iptg
treatment
level
return
background
state
anim
within
hour
similarli
iptg
given
ip
inject
rapid
luciferas
induct
observ
within
hour
figur
previous
demonstr
sirna
target
bacteri
lac
repressor
codeliv
report
repressor
plasmid
construct
restor
luciferas
activ
level
observ
absenc
repressor
compar
iptgmedi
induct
studi
mammalian
version
lac
repressor
use
allow
longterm
express
transgen
mice
three
new
sirna
sequenc
design
test
follow
transient
transfect
cell
placir
variou
sirna
silac
sequenc
mediat
substanti
uninduc
state
lac
repressor
laci
transcrib
translat
protein
laci
bind
lac
oper
laco
locat
within
promot
intron
upstream
luciferas
gene
suppress
report
gene
express
iptg
alter
conform
laci
prevent
bind
laco
allow
luciferas
express
sirna
specif
target
laci
mrna
caus
repressor
protein
level
fall
permit
luciferas
express
b
plasmid
vector
employ
induc
luciferas
express
system
phdlacoluc
creat
ryan
et
al
contain
firefli
luciferas
vector
promega
control
hd
promot
insert
two
synthet
lac
oper
placir
creat
cronin
et
al
express
mammalian
version
lac
repressor
driven
kb
fragment
human
promot
flank
segment
rabbit
locu
reduct
lac
express
figur
silac
demonstr
greatest
effect
protein
express
undetect
even
lowest
nmoll
sirna
dose
cell
receiv
nonlac
target
sirna
includ
sirna
target
bacteri
version
repressor
show
reduct
lac
express
importantli
silac
effect
level
luciferas
express
codeliv
phdlacoluc
figur
confirm
sequenc
offtarget
effect
luciferas
mrna
identifi
potent
sequenc
second
sirna
contain
serum
stabil
modif
sistablesilac
synthes
prepar
vivo
deliveri
applic
cotransfect
sistablesilac
placir
reduc
repressor
express
level
compar
unmodifi
silac
sequenc
figur
control
sistabl
sequenc
littl
effect
silac
sistablelac
assess
abil
restor
luciferas
express
use
transient
cotransfect
assay
involv
deliveri
four
compon
includ
report
hdlacoluc
repressor
lacir
plasmid
control
renilla
luciferas
express
plasmid
silac
sistablelac
figur
howev
reduct
luciferas
express
small
sinc
hdlacoluc
deliv
tenfold
excess
compar
lacir
limit
transcript
interfer
promot
drive
lacir
weaker
hd
promot
drive
luciferas
thu
reduc
express
transient
assay
data
shown
expect
lac
repressormedi
fall
luciferas
express
fulli
restor
induct
mmoll
iptg
importantli
codeliveri
sirna
target
repressor
silac
sistablelac
also
fulli
restor
luciferas
express
control
sirna
sihbsag
sistablecont
effect
result
confirm
silac
sistablelac
capabl
downregul
lac
repressor
cell
bear
dual
express
system
mediat
rise
report
gene
express
result
posit
readout
gener
rnai
activ
final
test
effect
deliv
sirna
target
lac
repressor
luciferas
express
mous
model
individu
mice
shown
evid
iptg
induct
inject
ip
complex
sistablelac
lipofectamin
repres
exampl
shown
figur
follow
administr
increas
luciferas
express
observ
periton
region
like
includ
surfac
liver
possibl
organ
enabl
comparison
individu
mice
week
ensur
restor
basal
express
level
occur
control
sirna
sint
administ
dose
increas
luciferas
express
detect
figur
also
test
intramuscular
administr
nake
sirna
howev
expect
absenc
electropor
increas
luciferas
express
observ
data
shown
scrabl
et
al
previous
develop
luciferaseexpress
lac
repressor
model
order
visual
dynam
gene
express
realtim
live
mous
recapitul
model
provid
posit
readout
sirna
activ
origin
scrabl
et
al
report
upon
iptg
induct
bodywid
luciferas
express
fell
back
induc
level
hour
return
initi
background
level
day
mice
gener
studi
appear
rapid
kinet
sinc
luciferas
express
return
background
within
hour
iptg
remov
result
appear
respons
anim
first
studi
possibl
result
greater
repressor
protein
express
luciferas
express
variabl
among
singl
transgen
offspr
founder
mous
howev
signific
repress
luciferas
express
observ
doubl
transgen
progeni
mice
result
cross
line
lac
repressor
express
robust
ubiquit
luciferas
express
level
within
individu
doubl
transgen
mice
stabl
month
case
chang
increas
signal
observ
due
hair
loss
elderli
mice
despit
signific
degre
luciferas
repress
hdlacoluc
x
lacir
mice
individu
examin
show
level
luciferas
express
low
wildtyp
lacir
mice
consequ
hand
particular
mate
system
appear
slightli
leaki
complet
repress
rare
obtain
also
high
degre
animaltoanim
variabl
luciferas
express
doubl
transgen
need
address
widespread
practic
applic
test
model
inbreed
may
help
reduc
variabl
individu
believ
situat
incomplet
repress
could
improv
use
addit
regulatori
factor
genet
switch
propos
dean
et
al
author
develop
cassett
compris
short
hairpin
rna
construct
target
report
gene
whose
express
control
anoth
repressor
tet
turn
regul
lac
oper
site
locat
within
promot
consequ
state
lac
repressor
prevent
express
report
gene
repress
express
tet
repressor
time
express
hairpin
rna
occur
reduc
residu
report
gene
express
induct
achiev
iptg
allow
report
gene
express
combin
releas
lac
oper
site
locat
within
report
gene
promot
also
promot
tetr
result
tetr
express
repress
short
hairpin
rna
express
refer
system
one
would
envisag
sirna
target
lacr
would
function
manner
iptg
thu
give
rise
luciferas
express
system
less
prone
leaki
nevertheless
induct
luciferas
current
model
rapid
mice
given
iptg
either
via
oral
ip
rout
degre
luciferas
induct
variabl
individu
fell
rapidli
iptg
remov
suggest
reexpress
repressor
protein
silenc
report
import
determin
sensit
readout
model
applic
uncomplex
nake
sistablelac
thigh
muscl
fail
induc
luciferas
signal
presum
sinc
sirna
enter
cell
effect
absenc
entri
mechan
electropor
contrast
lipofectamin
complex
serum
stabil
sirna
dose
mgkg
administ
ip
rout
result
threefold
increas
luciferas
express
compar
neg
control
sirna
periton
organ
confirm
potenti
model
identifi
sirna
activ
express
observ
dose
reduc
mgkg
data
shown
lipofectamin
particularli
sophist
vivo
deliveri
vector
like
effect
vehicl
yield
greater
respons
furthermor
limit
detect
may
reduc
induct
obtain
organ
greater
depth
skin
one
applic
model
would
compar
commerci
avail
deliveri
system
determin
optim
research
particular
requir
shen
colleagu
abbott
laboratori
develop
positivereadout
cellular
model
base
tet
repressor
system
tet
repressor
protein
bind
tet
oper
site
locat
within
luciferas
promot
use
specif
sirna
target
tet
repressor
result
increas
luciferas
express
thu
posit
readout
sirna
activ
encod
system
cancer
cell
line
abl
implant
tumor
xenograft
nude
mice
rat
compar
rang
deliveri
vector
tumor
target
conclud
mg
sirnakg
formul
dodapbas
liposom
avanti
polar
lipid
snalpbas
liposom
system
capabl
deliveri
liver
tumor
follow
intraven
inject
valuabl
assay
system
provid
inform
regard
activ
sirna
rodent
cell
ie
target
term
cellular
target
achiev
use
transgen
model
everi
cell
express
report
system
one
describ
mice
would
refractori
develop
human
tumor
xenograft
would
possibl
encod
repressor
system
mous
tumor
line
could
provid
model
tumor
target
altern
envisag
orthotop
tumor
model
could
develop
target
specif
organ
metastas
might
provid
realist
model
c
cell
transient
transfect
placir
without
sirna
final
concentr
indic
use
lipofectamin
cell
lyse
hour
c
hour
sampl
run
acrylamid
gel
transfer
onto
nitrocellulos
blot
presenc
mammalian
lac
repressor
use
antilac
antibodi
blot
strip
reprob
antitubulin
antibodi
load
control
b
cell
transfect
triplic
phdlacoluc
either
alon
nmoll
siluc
silac
luciferas
express
determin
hour
normal
protein
content
cell
transfect
n
plasmid
dna
sirna
shown
mmoll
iptg
ad
appropri
cell
hour
firefli
renilla
luciferas
express
measur
hour
express
normal
divid
rlu
firefli
luciferas
rlu
renilla
luciferas
statist
analysi
perform
use
leven
statist
confirm
homogen
varianc
follow
analysi
varianc
use
bonferonni
correct
post
hoc
analysi
p
laclr
laclr
nmoll
laclr
nmoll
laclr
nmoll
laclr
nmoll
laclr
nmoll
laclr
nmoll
laclr
nmoll
siluc
laclr
nmoll
sigfp
laclr
nmoll
silac
bacteri
laclr
nmoll
laclr
nmoll
laclr
nmol
instead
instanc
silenc
occur
via
nonspecif
mechan
activ
fact
sirnaclass
effect
author
demonstr
inhibit
blind
choroid
neovascular
model
agerel
macular
degener
mice
effect
use
control
nonspecif
sirna
administr
sirna
target
vegfa
effect
could
occur
via
cell
surfac
tolllik
adaptor
trif
induct
use
positivereadout
report
system
would
help
address
issu
rnai
versu
activ
exampl
inject
cocktail
sirna
target
vegfa
control
togeth
silacor
control
eye
report
mice
given
laserinjuri
induc
choroid
neovascular
model
predict
efficaci
human
could
help
show
suppress
choroid
neovascular
effect
mediat
rnai
luciferas
induct
would
observ
luciferas
signal
would
seen
current
model
limit
high
interanim
variat
baselin
luciferas
express
iptg
induct
howev
test
sirna
activ
possibl
use
individu
compar
luciferas
induct
achiev
silac
level
observ
subsequ
deliv
nontarget
sirna
intern
control
studi
manner
circumv
issu
variabl
suffici
allow
us
demonstr
posit
readout
sirna
activ
achiev
although
develop
requir
widespread
practic
applic
believ
dynam
rapidli
respons
positivereadout
report
model
sirna
pharmacodynam
great
potenti
improv
sirna
vector
design
test
acceler
develop
new
wave
genet
medicin
treat
rang
disord
plasmid
dna
regulat
hdlacoluc
construct
express
firefli
luciferas
driven
promot
human
huntington
diseas
hd
locu
embed
two
synthet
lac
oper
hd
promot
fragment
obtain
ncoi
digest
construct
david
housman
hdf
chdi
reagent
resourc
bank
contain
huntingtin
promot
exon
yield
bp
product
insert
ncoi
site
vector
promega
madison
wi
two
synthet
lac
oper
attgtgagcgctcacaat
insert
locat
flank
transcript
start
site
mimick
space
found
lac
operon
e
coli
use
splice
overlap
extens
pcr
uniqu
site
hd
promot
lacir
construct
contain
lac
repressor
transgen
resembl
typic
mammalian
gene
term
codon
usag
control
human
promot
supplementari
figur
express
renilla
luciferas
control
hsvtk
promot
promega
southampton
uk
sirna
sirna
target
mammalian
version
lac
repressor
design
use
dharmacon
design
softwar
sequenc
silac
mrna
target
sequenc
nnagaaagaaguggaguugaa
silac
mrna
target
sequenc
nngccaauagcugaaagagaa
silac
mrna
target
sequenc
nngaagacagcucauguuaua
synthes
thermo
fisher
scientif
cramlington
uk
chemic
stabil
version
silac
sistablelac
convert
version
togeth
nontarget
sirna
control
thermo
scientif
dharmacon
also
synthes
sirna
target
gfp
sigfp
mrna
target
sequenc
cggcaagcugacccugaaguucau
luciferas
siluc
mrna
target
sequenc
aacuuacgcugaguacuucga
bacteri
laci
mrna
target
sequenc
aaauaucucacucgcaaucaa
sirna
target
hepat
b
surfac
antigen
sihbsag
mrna
target
sequenc
aacaucacaucaggauuccua
sihbsag
mrna
target
sequenc
aaucacucaccaaccucuugu
sihbsag
mrna
target
sequenc
cuauauggaugauguggua
synthes
qiagen
crawley
uk
cell
murin
fibroblast
obtain
atcc
manassa
va
maintain
dmem
contain
fetal
calf
serum
human
prostat
carcinoma
cell
maintain
ham
media
contain
fetal
calf
serum
transfect
assay
test
efficaci
sirna
sequenc
target
lac
repressor
cell
plate
sixwel
plate
placir
transfect
alon
combin
variou
sirna
final
concentr
nmoll
use
lipofectamin
invitrogen
paisley
uk
serumfre
medium
accord
manufactur
instruct
hour
serum
contain
media
ad
give
final
serum
concentr
cell
lyse
hour
analyz
lacir
protein
express
western
blot
assay
determin
efficaci
sistablelac
examin
hour
rather
hour
assess
offtarget
effect
silac
luciferas
express
cell
plate
plate
hdlacoluc
alon
siluc
silac
nmoll
final
concentr
complex
lipofectamin
ad
cell
cell
lyse
hour
luciferas
express
measur
use
luciferas
assay
reagent
promega
southampton
uk
luminomet
berthold
technolog
harpenden
uk
read
normal
protein
content
assess
efficaci
sirna
context
report
system
cell
plate
plate
ng
hdlacoluc
ng
ad
cell
alon
togeth
ng
lacir
use
lipofectamin
addit
cell
receiv
nmoll
sirna
deliv
within
lipofectamin
complex
plasmid
dna
cell
transfect
replic
five
experi
perform
least
three
occas
hour
appropri
cell
receiv
mmoll
iptg
hour
cell
lyse
luciferas
express
analyz
firefli
renilla
luciferas
measur
use
dual
glow
report
system
promega
southampton
uk
read
normal
protein
content
express
ratio
firefli
luciferas
express
divid
renilla
luciferas
express
statist
analysi
perform
use
leven
statist
confirm
homogen
varianc
follow
analysi
varianc
use
bonferonni
correct
post
hoc
analysi
western
blot
transfect
cell
lyse
total
cellular
protein
extract
use
mper
solut
pierc
biotechnolog
rockford
il
contain
proteas
inhibitor
cocktail
roch
welwyn
garden
citi
uk
protein
concentr
determin
bca
assay
total
protein
load
onto
well
sdspage
gel
run
v
minut
protein
transfer
nitrocellulos
membran
block
dri
milk
trisbuff
salin
ph
tween
tbst
room
temperatur
minut
blot
wash
three
time
tbst
incub
mous
antilaci
clone
primari
antibodi
millipor
uk
watford
uk
dilut
room
temperatur
hour
blot
wash
three
time
tbst
incub
goat
antimous
igghrp
secondari
antibodi
dako
eli
uk
dilut
room
temperatur
hour
blot
wash
band
visual
chemiluminesc
use
ecl
western
blot
detect
reagent
ge
healthcar
littl
chalfont
uk
chemiimag
alpha
innotech
san
leandro
ca
analyz
use
fluorchem
softwar
blot
strip
reprob
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
dilut
protein
load
control
transgen
mous
product
hdlacoluc
transgen
mice
gener
isol
transgen
construct
phdlacoluc
via
bgliibamhi
digest
figur
follow
pvui
digest
leav
kb
isol
fragment
purifi
dilut
microinject
buffer
mmoll
trishcl
mmoll
edta
lacir
transgen
mice
gener
isol
transgen
construct
placir
via
kpnisaci
partial
digest
figur
give
kb
fragment
isol
purifi
describ
threeweekold
femal
mice
superovul
mate
result
fertil
oocyt
collect
oviduct
plug
femal
mice
cultur
two
clear
pronuclei
visibl
purifi
hdlacoluc
lacir
transgen
construct
microinject
one
pronuclei
inject
embryo
cultiv
overnight
twocel
stage
twocel
embryo
reimplant
oviduct
pseudo
pregnant
foster
mother
day
coitum
day
later
pup
born
foster
mother
ear
biopsi
pup
taken
dna
extract
pcr
perform
identifi
transgen
founder
mice
founder
mice
mate
mice
result
pup
genotyp
confirm
germlin
transmiss
transgen
transgen
mate
mice
produc
gener
establish
line
doubl
transgen
establish
mate
hdlacoluc
transgen
mice
lacir
transgen
mice
offspr
genotyp
identifi
individu
carri
transgen
genotyp
pcr
pcr
primer
hdlacoluc
forward
hdlacoluc
revers
lacir
forward
lacir
revers
sigma
genosi
welwyn
garden
citi
uk
design
amplifi
bp
region
hdlacoluc
bp
region
lacir
templat
dna
obtain
ear
biopsi
amplifi
use
thermal
cycl
condit
minut
follow
cycl
second
second
second
end
singl
complet
stage
minut
reaction
condit
gener
appli
biosystem
sequenc
detect
system
standard
amplif
reaction
contain
quantitect
probe
pcr
mastermix
includ
hotstartaqdna
polymeras
trishcl
kcl
nh
mmoll
mgcl
dntp
rox
passiv
refer
dye
qiagen
ad
nmoll
forward
primer
nmoll
revers
primer
two
microlitr
templat
dna
sampl
ad
posit
control
perform
use
ng
plasmid
hdlacoluc
lacir
dna
neg
control
perform
use
water
instead
templat
control
integr
sampl
dna
confirm
pcr
use
murin
connexin
primer
forward
primer
revers
primer
vivo
imag
mice
anesthet
isofluoran
inject
intraperiton
steril
filter
mgml
dluciferin
gold
biotechnolog
st
loui
mo
pb
minut
mice
imag
use
ivi
system
xenogen
alameda
ca
imag
captur
use
live
imag
softwar
requir
whole
bodi
imag
mice
cull
dissect
organ
arrang
reimag
outsid
carcass
induct
luciferas
iptg
mice
imag
given
either
mmoll
iptg
stratagen
leicest
uk
drink
water
mmoll
iptg
administ
intraperiton
reimag
hour
later
mice
show
evid
luciferas
induct
upon
iptg
induct
given
intraperiton
inject
sirna
sistablelac
complex
lipofectamin
mgkg
imag
hour
mice
show
increas
luciferas
express
treat
week
later
nontarget
control
sirna
complex
lipofectamin
dose
mice
also
given
intramuscular
inject
nake
sirna
sistablelac
one
thigh
nontarget
control
sirna
opposit
thigh
muscl
reimag
hour
figur
construct
lacir
code
sequenc
tabl
mean
luciferas
express
mous
